H5N1 vaccines in humans
- 1 December 2013
- journal article
- review article
- Published by Elsevier in Virus Research
- Vol. 178 (1) , 78-98
Abstract
No abstract availableKeywords
This publication has 180 references indexed in Scilit:
- Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 studyThe Lancet Infectious Diseases, 2013
- An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adultsVaccine, 2011
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunityVaccine, 2011
- H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell ResponsesJournal of Clinical Immunology, 2010
- The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virusVirology, 2009
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adultsVaccine, 2008
- The perfect mix: recent progress in adjuvant researchNature Reviews Microbiology, 2007
- Strategies for mitigating an influenza pandemicNature, 2006
- Baculovirus as versatile vectors for protein expression in insect and mammalian cellsNature Biotechnology, 2005